US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist

12.930
+0.150+1.17%

Trading Dec 2 09:49 ET

314.06MMarket Cap-5124P/E (TTM)

Artiva Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Artiva Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 60.000K	--
--	2024/Q3	0.000 / 75.000K	--
--	2024/Q2	0.000 / 75.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 60.000K--

--2024/Q30.000 / 75.000K--

--2024/Q20.000 / 75.000K--

--------

Unlock Free Earnings Estimates

Open Account

Artiva Biotherapeutics Earnings Reports

Artiva Biotherapeutics | 10-Q: Quarterly report

Nov 12 16:16 ET

Artiva Biotherapeutics | 8-K: Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 12 16:14 ET

Artiva Biotherapeutics | 10-Q: Quarterly report

Aug 29 16:23 ET

Artiva Biotherapeutics | 8-K: Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 29 16:22 ET

Analyst Rating

Updated: Nov 30, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall